Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial
-
Published:2021-01
Issue:
Volume:31
Page:100689
-
ISSN:2589-5370
-
Container-title:EClinicalMedicine
-
language:en
-
Short-container-title:EClinicalMedicine
Author:
Tebas Pablo, Yang ShuPing, Boyer Jean D., Reuschel Emma L., Patel Ami, Christensen-Quick Aaron, Andrade Viviane M., Morrow Matthew P., Kraynyak Kimberly, Agnes Joseph, Purwar Mansi, Sylvester Albert, Pawlicki Jan, Gillespie Elisabeth, Maricic Igor, Zaidi Faraz I., Kim Kevin Y., Dia Yaya, Frase Drew, Pezzoli Patrick, Schultheis Katherine, Smith Trevor R.F., Ramos Stephanie J., McMullan Trevor, Buttigieg Karen, Carroll Miles W., Ervin John, Diehl Malissa C., Blackwood ElliottORCID, Mammen Mammen P., Lee Jessica, Dallas Michael J., Brown Ami Shah, Shea Jacqueline E., Kim J.Joseph, Weiner David B., Broderick Kate E., Humeau Laurent M.
Funder
Coalition for Epidemic Preparedness Innovations
Reference33 articles.
1. Robust antibody and cellular responses induced by DNA-only vaccination for HIV;De Rosa;JCI Insight,2020 2. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial;Modjarrad;Lancet Infect Dis,2019 3. Intradermal SynCon(R) ebola GP DNA vaccine is temperature stable and safely demonstrates cellular and humoral immunogenicity advantages in healthy volunteers;Tebas;J Infect Dis,2019 4. Safety and immunogenicity of an anti-Zika virus DNA vaccine – preliminary report;Tebas;N Engl J Med,2017 5. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial;Trimble;Lancet,2015
Cited by
207 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|